# Intramammary Dosage Forms; Ceftiofur
> **Food and Drug Administration** · Final rule. · Published 2005-02-28 · Effective 2005-02-28 · 70 FR 9515
## Document
- **Document number:** 05-3834
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 70 FR 9515
- **CFR reference:** 21 CFR 526
- **Publication date:** 2005-02-28
- **Effective date:** 2005-02-28
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The NADA provides for the veterinary prescription use of ceftiofur hydrochloride suspension, by intramammary infusion, for the treatment of clinical mastitis in lactating dairy cattle.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2005/02/28/05-3834/intramammary-dosage-forms-ceftiofur)
---
*AI Analytics · CC0 1.0*